5 most read GI/endoscopy stories — Dec. 12, 2016

Here are the five most read gastroenterology/endoscopy stories for the week of Dec. 12, 2016.

Advertisement

1. Valeant, Takeda deal crumbles; Valeant to invest in Salix: 6 things to know
Click here

2. Metastatic tumor-destroying vaccine for colon cancer patients to begin phase II trial: 6 key notes
Click here

3. GI societies objects to American Board of Internal Medicine’s certification proposals: 4 notes
Click here

4. How LifeBond is trying to solve a surgeon’s biggest headache
Click here

5. Invendo receives CE Mark for sterile, single-use endoscope: 5 things you need to know
Click here

More articles on gastroenterology/endoscopy:
Dr. Albert Czaja receives Mayo Clinic award & more — 3 GI physicians in the headlines
NCI scientists reverse a woman’s colon cancer with immunotherapy: 5 research insights
GI leader to know: Dr. Kumar Gutta of Gastroenterology Associates of North Texas

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.